Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,368 | 62,822 | 68,629 | 68,740 | 70,651 |
| Receivables | 28,357 | 33,773 | 32,077 | 26,360 | 34,682 |
| Inventories | 39,629 | 51,464 | 49,408 | 24,428 | 43,724 |
| Other current assets | 0 | 0 | 0 | 36,305 | 0 |
| TOTAL | $136,106 | $155,000 | $158,962 | $163,309 | $156,778 |
| Non-Current Assets | |||||
| PPE Net | 44,572 | 47,685 | 46,057 | 37,445 | 45,937 |
| Intangibles | 10,737 | 11,319 | 11,700 | 10,147 | 76,015 |
| Other Non-Current Assets | 39,990 | 48,651 | 47,025 | 59,731 | 49,428 |
| TOTAL | $95,299 | $107,655 | $104,782 | $107,323 | $171,380 |
| Total Assets | $231,405 | $262,655 | $263,744 | $270,632 | $328,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,805 | 9,994 | 10,022 | 6,194 | 8,251 |
| Accrued Expenses | 18,688 | 16,127 | 18,438 | 14,066 | 19,813 |
| Other current liabilities | N/A | N/A | N/A | 10,799 | N/A |
| TOTAL | $25,493 | $26,121 | $28,460 | $31,059 | $28,064 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 26,048 | 26,196 | 26,748 | 27,308 | 27,653 |
| TOTAL | $26,048 | $26,196 | $26,748 | $27,308 | $29,608 |
| Total Liabilities | $51,541 | $52,317 | $55,208 | $58,367 | $57,672 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,646 | 14,797 | 14,828 | 14,850 | 14,641 |
| Common Shares | 147 | 148 | 148 | 147 | 146 |
| Retained earnings | 93,532 | 123,450 | 123,538 | 128,052 | 191,052 |
| Other shareholders' equity | -5,701 | -6,416 | -6,315 | -5,943 | -6,564 |
| TOTAL | $179,864 | $210,338 | $208,536 | $212,265 | $270,486 |
| Total Liabilities And Equity | $231,405 | $262,655 | $263,744 | $270,632 | $328,158 |